Found 4 hits for monomerid = 50007245 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007245
(CHEMBL3238234)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCCC(O)=O |r,wU:6.5,15.19,wD:12.13,c:10,(3.27,-43.71,;3.25,-42.17,;1.91,-41.41,;1.91,-42.92,;4.58,-41.38,;4.56,-39.84,;5.88,-39.06,;5.83,-37.52,;7.04,-36.57,;8.52,-36.98,;6.51,-35.12,;4.96,-35.18,;4.55,-36.66,;3.36,-35.67,;1.91,-36.21,;1.65,-37.72,;2.84,-38.71,;4.28,-38.18,;.31,-38.48,;-1.02,-37.71,;.3,-40.02,;-1.03,-39.24,;7.28,-33.79,;6.52,-32.46,;7.3,-31.13,;6.53,-29.79,;8.84,-31.13,;9.6,-32.47,;11.14,-32.48,;8.83,-33.8,;7.21,-39.84,;7.18,-41.39,;8.51,-42.17,;9.86,-41.42,;9.88,-39.88,;8.55,-39.1,;11.18,-42.21,;11.16,-43.75,;12.52,-41.46,;13.84,-42.24,;13.83,-43.78,;15.15,-44.57,;15.14,-46.1,;16.5,-43.81,)| Show InChI InChI=1S/C35H45Cl2N3O4/c1-33(2,3)15-13-28(22-7-9-23(10-8-22)31(43)38-18-14-29(41)42)40-32(44)30(24-19-26(36)21-27(37)20-24)39-35(40)16-11-25(12-17-35)34(4,5)6/h7-10,19-21,25,28H,11-18H2,1-6H3,(H,38,43)(H,41,42)/t25-,28-,35-/m1/s1 | PDB MMDB
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]-glucagon from recombinant human GCGR expressed in CHO cells after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this Ligand-Target Pair | |
Glucagon-like peptide 1 receptor (GLP-1)
(Homo sapiens (Human)) | BDBM50007245
(CHEMBL3238234)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCCC(O)=O |r,wU:6.5,15.19,wD:12.13,c:10,(3.27,-43.71,;3.25,-42.17,;1.91,-41.41,;1.91,-42.92,;4.58,-41.38,;4.56,-39.84,;5.88,-39.06,;5.83,-37.52,;7.04,-36.57,;8.52,-36.98,;6.51,-35.12,;4.96,-35.18,;4.55,-36.66,;3.36,-35.67,;1.91,-36.21,;1.65,-37.72,;2.84,-38.71,;4.28,-38.18,;.31,-38.48,;-1.02,-37.71,;.3,-40.02,;-1.03,-39.24,;7.28,-33.79,;6.52,-32.46,;7.3,-31.13,;6.53,-29.79,;8.84,-31.13,;9.6,-32.47,;11.14,-32.48,;8.83,-33.8,;7.21,-39.84,;7.18,-41.39,;8.51,-42.17,;9.86,-41.42,;9.88,-39.88,;8.55,-39.1,;11.18,-42.21,;11.16,-43.75,;12.52,-41.46,;13.84,-42.24,;13.83,-43.78,;15.15,-44.57,;15.14,-46.1,;16.5,-43.81,)| Show InChI InChI=1S/C35H45Cl2N3O4/c1-33(2,3)15-13-28(22-7-9-23(10-8-22)31(43)38-18-14-29(41)42)40-32(44)30(24-19-26(36)21-27(37)20-24)39-35(40)16-11-25(12-17-35)34(4,5)6/h7-10,19-21,25,28H,11-18H2,1-6H3,(H,38,43)(H,41,42)/t25-,28-,35-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Antagonist activity at human GLP-1R expressed in CHO cells assessed as inhibition of GLP-1-stimulated cAMP production preincubated for 30 mins follow... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007245
(CHEMBL3238234)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCCC(O)=O |r,wU:6.5,15.19,wD:12.13,c:10,(3.27,-43.71,;3.25,-42.17,;1.91,-41.41,;1.91,-42.92,;4.58,-41.38,;4.56,-39.84,;5.88,-39.06,;5.83,-37.52,;7.04,-36.57,;8.52,-36.98,;6.51,-35.12,;4.96,-35.18,;4.55,-36.66,;3.36,-35.67,;1.91,-36.21,;1.65,-37.72,;2.84,-38.71,;4.28,-38.18,;.31,-38.48,;-1.02,-37.71,;.3,-40.02,;-1.03,-39.24,;7.28,-33.79,;6.52,-32.46,;7.3,-31.13,;6.53,-29.79,;8.84,-31.13,;9.6,-32.47,;11.14,-32.48,;8.83,-33.8,;7.21,-39.84,;7.18,-41.39,;8.51,-42.17,;9.86,-41.42,;9.88,-39.88,;8.55,-39.1,;11.18,-42.21,;11.16,-43.75,;12.52,-41.46,;13.84,-42.24,;13.83,-43.78,;15.15,-44.57,;15.14,-46.1,;16.5,-43.81,)| Show InChI InChI=1S/C35H45Cl2N3O4/c1-33(2,3)15-13-28(22-7-9-23(10-8-22)31(43)38-18-14-29(41)42)40-32(44)30(24-19-26(36)21-27(37)20-24)39-35(40)16-11-25(12-17-35)34(4,5)6/h7-10,19-21,25,28H,11-18H2,1-6H3,(H,38,43)(H,41,42)/t25-,28-,35-/m1/s1 | PDB MMDB
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-stimulated cAMP production preincubated for 30 mins follo... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this Ligand-Target Pair | |
Glucagon receptor
(Mus musculus) | BDBM50007245
(CHEMBL3238234)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCCC(O)=O |r,wU:6.5,15.19,wD:12.13,c:10,(3.27,-43.71,;3.25,-42.17,;1.91,-41.41,;1.91,-42.92,;4.58,-41.38,;4.56,-39.84,;5.88,-39.06,;5.83,-37.52,;7.04,-36.57,;8.52,-36.98,;6.51,-35.12,;4.96,-35.18,;4.55,-36.66,;3.36,-35.67,;1.91,-36.21,;1.65,-37.72,;2.84,-38.71,;4.28,-38.18,;.31,-38.48,;-1.02,-37.71,;.3,-40.02,;-1.03,-39.24,;7.28,-33.79,;6.52,-32.46,;7.3,-31.13,;6.53,-29.79,;8.84,-31.13,;9.6,-32.47,;11.14,-32.48,;8.83,-33.8,;7.21,-39.84,;7.18,-41.39,;8.51,-42.17,;9.86,-41.42,;9.88,-39.88,;8.55,-39.1,;11.18,-42.21,;11.16,-43.75,;12.52,-41.46,;13.84,-42.24,;13.83,-43.78,;15.15,-44.57,;15.14,-46.1,;16.5,-43.81,)| Show InChI InChI=1S/C35H45Cl2N3O4/c1-33(2,3)15-13-28(22-7-9-23(10-8-22)31(43)38-18-14-29(41)42)40-32(44)30(24-19-26(36)21-27(37)20-24)39-35(40)16-11-25(12-17-35)34(4,5)6/h7-10,19-21,25,28H,11-18H2,1-6H3,(H,38,43)(H,41,42)/t25-,28-,35-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 520 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Displacement of [125I]-glucagon from GCGR in mouse liver membranes after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this Ligand-Target Pair | |